Clinical Trial Update: Efficacy and Tolerability of Metamizol in Patients With Episodic Moderate Headache [Phase 3]

View source ↗

Summary

Phase 3 trial results evaluating the efficacy and tolerability of metamizol for episodic moderate headache (migraine disorders).

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Migraine Disorders

Drugs mentioned

• Metamizol (metamizol)

Snippet

Sponsor: Boehringer Ingelheim | Conditions: Migraine Disorders | Phase 3 | Status: COMPLETED